Transcriptional control of c-jun by retinoic acid.
AUTOR(ES)
de Groot, R P
RESUMO
The proto-oncogene c-jun, a major component of transcription factor AP-1, is expressed at very low levels in undifferentiated embryonal carcinoma (EC) end embryonic stem (ES) cells. Retinoic acid (RA) induced differentiation causes a strong increase in the levels of c-jun mRNA. In this paper we report the cloning and characterization of the mouse c-jun promoter. Our results show that RA treatment causes a strong enhancement in c-jun promoter activity, an effect probably mediated by the RA-receptor beta (RAR beta). Sequences located between -329 and -293 are responsible for the observed RA effect, and bind at least five different protein complexes, of which three are decreased upon RA treatment. These protein binding sites do not resemble RA-responsive elements (RARE's) found in the promoters of retinoic acid receptor beta (RAR beta) and laminin B1. Furthermore, we could not detect a direct interaction of RAR alpha and RAR beta to these sequences, indicating that RA-induced c-jun expression is an indirect effect of RAR action.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=333919Documentos Relacionados
- Transcriptional regulation of the c-jun gene by retinoic acid and E1A during differentiation of F9 cells.
- c-jun inhibits transcriptional activation by the insulin enhancer, and the insulin control element is the target of control.
- Control of cell cycle progression by c-Jun is p53 dependent
- Activation of c-Jun N-Terminal Kinase 1 by UV Irradiation Is Inhibited by Wortmannin without Affecting c-jun Expression
- Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase
